Mirum Pharmaceuticals, Inc.
volixibat
primary sclerosing cholangitis (PSC)
Countdown
177days
Catalyst readout · ~ Dec 31, 2026 estimated
What's at stake
A key catalyst for volixibat (primary sclerosing cholangitis (PSC)) is expected ~ Dec 31, 2026.
Primary source
· SEC 8-K
verified 15h ago
“U.S. NDA submission expected in H2 2026”